Wade Jeffrey L
- SEC CIK
- 0001225767
No open-market purchases or sales filed in the past year.
Current role at each company
- LXRX Lexicon Pharmaceuticals, Inc.President and COOas of Jul 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wade Jeffrey L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 14 | Same day | Wade Jeffrey LPresident and CFO | PPurchase | +10.0K | $1.38 | +$13.8K | +3.9%264.3K after | |
| Jun 20, 2023 (view filing) | Jun 20 | Same day | Wade Jeffrey LPresident and CFO | PPurchase | +12.0K | $2.34 | +$28.1K | +5.0%254.3K after | 2 lots |